MedTrace Logo

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

NCT01010932 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2016-06-16

Study results available
· View outcomes & findings →

Summary

The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.

Conditions

  • Cerebral Arterial Diseases

Interventions

DRUG

Dotarem

Each subject will receive one injection of Dotarem 0.2ml/kg

OTHER

TOF MRA

Each subject will undergo a Time of Flight Magnetic Resonance Angiography (TOF MRA)

Sponsors & Collaborators

  • Guerbet

    lead INDUSTRY

Principal Investigators

  • Pierre DESCHE, MD · Guerbet

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01010932 on ClinicalTrials.gov